93 5721 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))
Pill with imprint 93 5721 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Teva Pharmaceuticals USA Inc..
Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for 93 5721
Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)
- Imprint
- 93 5721
- Strength
- 8 mg (base) / 2 mg (base)
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-5721
- Inactive Ingredients
-
acesulfame potassium,
citric acid anhydrous,
corn starch,
lactose monohydrate,
magnesium stearate,
mannitol,
povidone k30,
trisodium citrate dihydrate
Note: Inactive ingredients may vary.
More about buprenorphine / naloxone
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1009 Reviews
- Drug class: narcotic analgesic combinations
- FDA Alerts (1)
Consumer resources
- Patient Information
- Buprenorphine/naloxone Oromucosal, Sublingual (Advanced Reading)
- Buprenorphine and Naloxone Buccal Film
- Buprenorphine and Naloxone Sublingual Tablets
- Buprenorphine and Naloxone Sublingual Film (Suboxone)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.